OSR Holdings, Inc. (OSRH)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kuk Hyoun Hwang | Chairman & CEO | -- | -- | 1976 |
| Mr. Gihyoun Bang | Chief Financial Officer | 47.37k | -- | 1978 |
| Mr. Sang Hoon Kim | Head of Corporate Venture Capital | 84.02k | -- | 1974 |
| Dr. Constance Hofer | Chief Scientific Officer | -- | -- | 1969 |
| Mr. Jun Chul Whang | Chief Legal Officer, Secretary & Director | -- | -- | 1965 |
OSR Holdings, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 19
Description
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available